EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EPY001, a Novel Monoclonal Antibody Against Pseudomonas aeruginosa Targeting OprF

Guillaume Lacroix iD, Jean-Luc Lenormand

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Guillaume Lacroix und 1 weiteren Autor:innen. Beteiligte Einrichtung: Epynext Therapeutics, 38000 Grenoble, France. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Pseudomonas aeruginosa, Antibodies, Bacterial, Bacterial Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Epynext Therapeutics, Private company, Epynext Therapeutics. Grant: I-Lab 2021 Bpifrance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa (P. aeruginosa) is a high-priority opportunistic pathogen responsible for severe healthcare-associated infections exhibiting multidrug resistance, emphasizing the urgent need for alternative therapeutic strategies. Monoclonal antibodies (mAbs) targeting the highly conserved outer membrane protein OprF represent a promising approach to mitigate its infectivity. OprF, the major and highly conserved outer membrane protein of P. aeruginosa, plays key roles in the pathogenesis of this bacterium, including biofilm formation, host cell adhesion, immune sensing, and resistance to macrophage clearance, making it a crucial factor in virulence and a promising immunotherapeutic target. Here, we report the preclinical evaluation of EPY001, an anti-OprF mAb generated by immunization of a macaque with OprF-containing proteoliposomes. EPY001 exhibited strong nanomolar binding to OprF. Epitope mapping suggests recognition of a conformational epitope, underscoring the value of proteoliposome-based immunization for membrane protein targets. Functional assays provide insights into OprF’s role in biofilm formation, pyocyanin production, and antibiotic resistance. However, in vivo studies revealed that targeting OprF alone is insufficient to protect mice from lethal infection. These findings contribute to ongoing efforts to develop effective alternatives to conventional antibiotics against this resilient pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalPseudomonas aeruginosaAntibodies, BacterialBacterial ProteinsPseudomonas InfectionsAnimalsMacacaEpitope MappingProteolipidsImmunizationBiofilmsPyocyanineDrug Resistance, BacterialMiceMice, Inbred C57BLMaleDisease Models, Animal

Stichwörter der Autor:innen

Antimicrobial ResistanceOprFPseudomonas aeruginosamonoclonal antibodyproteoliposome

Substanzen

Antibodies, MonoclonalAntibodies, BacterialOprF protein, Pseudomonas aeruginosaBacterial ProteinsproteoliposomesProteolipidsPyocyanine

Autor:innen und Institutionen

  • Epynext Therapeutics, 38000 Grenoble, France.
  • Institut de Biologie Structurale (IBS), Université Grenoble Alpes (UGA), Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
  • CNRS, UMR5525, VetAgro Sup, Grenoble INP, TIMC, University Grenoble Alpes, 38000 Grenoble, France.

ORCID-Profile: Guillaume Lacroix

Förderung

  • Epynext Therapeutics, Private company
  • Epynext Therapeutics. Grant: I-Lab 2021 Bpifrance

Zitieren

APA

Lacroix, G., & Lenormand, J. L. (2025). EPY001, a Novel Monoclonal Antibody Against Pseudomonas aeruginosa Targeting OprF. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110380

Vancouver

Lacroix G, Lenormand JL. EPY001, a Novel Monoclonal Antibody Against Pseudomonas aeruginosa Targeting OprF. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110380

BibTeX
@article{Lacroix2025,
  author = {Lacroix, Guillaume and Lenormand, Jean-Luc},
  title = {EPY001, a Novel Monoclonal Antibody Against Pseudomonas aeruginosa Targeting OprF},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110380}
}
Kostenlos starten →